Literature DB >> 34059723

Ammonia-based enrichment and long-term propagation of zone I hepatocyte-like cells.

Ruri Tsuneishi1,2, Noriaki Saku1,3, Shoko Miyata1, Saeko Akiyama1, Palaksha Kanive Javaregowda1, Kenta Ite1, Nagisa Takashima1, Masashi Toyoda1,4, Tohru Kimura5, Masahiko Kuroda3, Atsuko Nakazawa1,6, Mureo Kasahara7, Hidenori Nonaka1, Akihide Kamiya8, Tohru Kiyono9, Junji Yamauchi2, Akihiro Umezawa10.   

Abstract

Ammonia has a cytotoxic effect and can therefore be used as a selection agent for enrichment of zone I hepatocytes. However, it has not yet been determined whether ammonia-treated hepatocyte-like cells are able to proliferate in vitro. In this study, we employed an ammonia selection strategy to purify hepatocyte-like cells that were differentiated from human embryonic stem cells (ESCs) and from induced pluripotent stem cells (iPSCs). The resistance to cytotoxicity or cell death by ammonia is likely attributable to the metabolism of ammonia in the cells. In addition to ammonia metabolism-related genes, ammonia-selected hepatocytes showed increased expression of the cytochrome P450 genes. Additionally, the ammonia-selected cells achieved immortality or at least an equivalent life span to human pluripotent stem cells without affecting expression of the liver-associated genes. Ammonia treatment in combination with in vitro propagation is useful for obtaining large quantities of hepatocytes.

Entities:  

Year:  2021        PMID: 34059723     DOI: 10.1038/s41598-021-90708-3

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  2 in total

1.  A synthetic nanofibrillar matrix promotes in vitro hepatic differentiation of embryonic stem cells and induced pluripotent stem cells.

Authors:  Taiji Yamazoe; Nobuaki Shiraki; Masashi Toyoda; Nobutaka Kiyokawa; Hajime Okita; Yoshitaka Miyagawa; Hidenori Akutsu; Akihiro Umezawa; Yutaka Sasaki; Kazuhiko Kume; Shoen Kume
Journal:  J Cell Sci       Date:  2013-10-07       Impact factor: 5.285

2.  Humanized liver mouse model with transplanted human hepatocytes from patients with ornithine transcarbamylase deficiency.

Authors:  Go Sugahara; Chihiro Yamasaki; Ami Yanagi; Suzue Furukawa; Yuko Ogawa; Akinari Fukuda; Shin Enosawa; Akihiro Umezawa; Yuji Ishida; Chise Tateno
Journal:  J Inherit Metab Dis       Date:  2020-12-30       Impact factor: 4.982

  2 in total
  2 in total

1.  Puromycin-based purification of cells with high expression of the cytochrome P450 CYP3A4 gene from a patient with drug-induced liver injury (DILI).

Authors:  Shoko Miyata; Noriaki Saku; Saeko Akiyama; Palaksha Kanive Javaregowda; Kenta Ite; Nagisa Takashima; Masashi Toyoda; Kei Yura; Tohru Kimura; Hiroshi Nishina; Atsuko Nakazawa; Mureo Kasahara; Hidenori Nonaka; Tohru Kiyono; Akihiro Umezawa
Journal:  Stem Cell Res Ther       Date:  2022-01-10       Impact factor: 6.832

2.  Drug metabolic activity is a critical cell-intrinsic determinant for selection of hepatocytes during long-term culture.

Authors:  Saeko Akiyama; Noriaki Saku; Shoko Miyata; Kenta Ite; Masashi Toyoda; Tohru Kimura; Masahiko Kuroda; Atsuko Nakazawa; Mureo Kasahara; Hidenori Nonaka; Akihide Kamiya; Tohru Kiyono; Tohru Kobayshi; Yasufumi Murakami; Akihiro Umezawa
Journal:  Stem Cell Res Ther       Date:  2022-03-12       Impact factor: 6.832

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.